Beta Bionics, Inc. (BBNX) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Beta Bionics, Inc. (BBNX) Company Statistics | The Fly

Beta Bionics, Inc.

· BBNX

Dashboard

Financials

KPIs

Ratios

Transcripts

Valuation

Statistics

1.047 B

-2.22%

General

Market Cap: $1.05B
Enterprise Value: $816.1M
Shares Outstanding: 44,990,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: 58.31%
Operating Margin: -69.75%
Net Profit Margin: -61.32%
FCF Margin: -51.60%
ROA: -24.96%
ROE: -26.30%
ROIC: -30.98%
Current Ratio: 8.88
Debt-to-Equity: 0.03
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: —
P/S: 7.17
P/FCF: —
P/B: 3.33
EV/EBITDA: -11.38

Growth

Rev 1Y: 53.94%
Rev 1Y Fwd Est: 26.36%
Rev 3Y (CAGR): 724.29%
Rev 5Y (CAGR): —
Rev 10Y (CAGR): —
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —
EPS 5Y (CAGR)

Income Statement (TTM)

Revenue: $119.01M
Gross Margin: 58.31%
Operating Expenses: $152.42M
Operating Income: -$83.02M
Net Profit: -$72.97M

Balance Sheet

—

EPS 10Y (CAGR)

—

Cash and Equivalents: $44.32M
Working Capital: $205.02M
Total Assets: $292.39M
Net Debt: -$37.81M
Total Liabilities: $36.02M
Total Equity: $256.37M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$55.81M
Cash Flow from Investing: $58.92M
Cash Flow from Financing: $6.14M
Free Cash Flow: -$61.41M
Capital Expenditures: $5.6M